Baum Hedlund staff and clients have attended Congressional drug safety hearings and several FDA drug safety hearings investigating the risks of SSRI-antidepressants. A Baum Hedlund attorney and several of our clients have testified on several occasions before the government regarding the need for proper drug safety warnings on antidepressants. Baum Hedlund has presented evidence about the dangers of SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants three times before the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee and once before the California State Senate. Baum Hedlund staff and clients have also met with FDA and Department of Health and Human Resources officials, as well as members of the U.S. House and Senate regarding the risk of antidepressant induced suicidality.
Our firm also assisted Congressional Investigators from two separate Committee investigations. Two Congressional hearings were later held at which pharmaceutical executives and FDA officials were interrogated for their failure to protect the public health related to antidepressants and their association with suicidality.
The FDA now requires a black box warning on all antidepressant labels alerting physicians and patients to the increased risk of suicidality.
Baum Hedlund has also represented more than 100 families of hemophiliacs infected by HIV contaminated blood-derived products (used by hemophiliacs for blood coagulation). It was considered one of the worst drug industry related medical disasters in history. As with all of its drug litigation, Baum Hedlund dug deep into drug company coffers to find the evidence of what went wrong. That information was not only used at trial, but also provided to authorities in various countries.
For more information and resources concerning antidepressants, visit antidepressantadversereactions.com.